160 related articles for article (PubMed ID: 23864185)
1. Prophylaxis against venous thromboembolism after arthroplasty: establishing value requires more than one perspective. Commentary on an article by John T. Schousboe, MD, PhD, and Gregory A. Brown, MD, PhD: "Cost-effectiveness of low-molecular-weight heparin compared with aspirin for prophylaxis against venous thromboembolism after total joint arthroplasty".
Yates AJ
J Bone Joint Surg Am; 2013 Jul; 95(14):e102 1-2. PubMed ID: 23864185
[No Abstract] [Full Text] [Related]
2. Cost-effectiveness of low-molecular-weight heparin compared with aspirin for prophylaxis against venous thromboembolism after total joint arthroplasty.
Schousboe JT; Brown GA
J Bone Joint Surg Am; 2013 Jul; 95(14):1256-64. PubMed ID: 23864173
[TBL] [Abstract][Full Text] [Related]
3. Comparative Effectiveness and Safety of Drug Prophylaxis for Prevention of Venous Thromboembolism After Total Knee Arthroplasty.
Cafri G; Paxton EW; Chen Y; Cheetham CT; Gould MK; Sluggett J; Bini SA; Khatod M
J Arthroplasty; 2017 Nov; 32(11):3524-3528.e1. PubMed ID: 28634095
[TBL] [Abstract][Full Text] [Related]
4. Low-Dose Aspirin Is Effective Chemoprophylaxis Against Clinically Important Venous Thromboembolism Following Total Joint Arthroplasty: A Preliminary Analysis.
Parvizi J; Huang R; Restrepo C; Chen AF; Austin MS; Hozack WJ; Lonner JH
J Bone Joint Surg Am; 2017 Jan; 99(2):91-98. PubMed ID: 28099298
[TBL] [Abstract][Full Text] [Related]
5. Aspirin and the prevention of venous thromboembolism following total joint arthroplasty: commonly asked questions.
Azboy I; Barrack R; Thomas AM; Haddad FS; Parvizi J
Bone Joint J; 2017 Nov; 99-B(11):1420-1430. PubMed ID: 29092979
[TBL] [Abstract][Full Text] [Related]
6. Venous thromboembolism debate in joint arthroplasty.
Lieberman JR; Barnes CL; Lachiewicz PF; Hanssen AD; Clarke HD; Pellegrini VD
J Bone Joint Surg Am; 2009 Aug; 91 Suppl 5():29-32. PubMed ID: 19648620
[No Abstract] [Full Text] [Related]
7. [Efficacy and safety of aspirin in prevention of venous thromboembolism after total joint arthroplasty].
Tian H; Song F; Zhang K; Liu Y
Zhonghua Yi Xue Za Zhi; 2007 Dec; 87(47):3349-52. PubMed ID: 18478950
[TBL] [Abstract][Full Text] [Related]
8. Aspirin and the Hip: Back to the Future? A 70-Year History: Commentary on an article by Leanne Ludwick, BS, et al.: "Aspirin May Be a Suitable Prophylaxis for Patients with a History of Venous Thromboembolism Undergoing Total Joint Arthroplasty".
Hernigou P
J Bone Joint Surg Am; 2022 Aug; 104(16):e74. PubMed ID: 35976188
[No Abstract] [Full Text] [Related]
9. Multimodal prophylaxis for venous thromboembolic disease after total hip and knee arthroplasty: current perspectives.
Lu N; Salvati EA
Chin J Traumatol; 2010 Dec; 13(6):362-9. PubMed ID: 21126395
[TBL] [Abstract][Full Text] [Related]
10. Low-molecular-weight heparin versus unfractionated heparin for prophylaxis of venous thromboembolism in medicine patients--a pharmacoeconomic analysis.
Wilbur K; Lynd LD; Sadatsafavi M
Clin Appl Thromb Hemost; 2011 Oct; 17(5):454-65. PubMed ID: 20699258
[TBL] [Abstract][Full Text] [Related]
11. The cost-effectiveness of oral direct factor Xa inhibitors compared with low-molecular-weight heparin for the prevention of venous thromboembolism prophylaxis in total hip or knee replacement surgery.
Mahmoudi M; Sobieraj DM
Pharmacotherapy; 2013 Dec; 33(12):1333-40. PubMed ID: 23625693
[TBL] [Abstract][Full Text] [Related]
12. Cost-effective prophylaxis against venous thromboembolism after total joint arthroplasty: warfarin versus aspirin.
Mostafavi Tabatabaee R; Rasouli MR; Maltenfort MG; Parvizi J
J Arthroplasty; 2015 Feb; 30(2):159-64. PubMed ID: 25534862
[TBL] [Abstract][Full Text] [Related]
13. Staged venous thromboemolic events prophylaxis with low-molecular-weight heparin followed by aspirin is safe and effective after arthroplasty.
Asopa V; Cobain W; Martin D; Keene G; Bauze A
ANZ J Surg; 2015 Sep; 85(9):652-7. PubMed ID: 25997601
[TBL] [Abstract][Full Text] [Related]
14. Direct Costs of Aspirin versus Warfarin for Venous Thromboembolism Prophylaxis after Total Knee or Hip Arthroplasty.
Gutowski CJ; Zmistowski BM; Lonner JH; Purtill JJ; Parvizi J
J Arthroplasty; 2015 Sep; 30(9 Suppl):36-8. PubMed ID: 26073347
[TBL] [Abstract][Full Text] [Related]
15. Challenging the assumptions about chemical thromboprophylaxis in knee replacement: commentary on an article by Alma B. Pedersen, MD, PhD, et al.: "Venous thromboembolism in patients having knee replacement and receiving thromboprophylaxis: a danish population-based follow-up study".
Leopold SS
J Bone Joint Surg Am; 2011 Jul; 93(14):e81. PubMed ID: 21792484
[No Abstract] [Full Text] [Related]
16. Dabigatran vs. low molecular weight heparin in preventing venous thromboembolism after elective hip and knee arthroplasty: evaluation of selected clinical parameters.
Mrozik D; Jackiewicz A; Krzemiński M
Pol Orthop Traumatol; 2012 Oct; 77():111-4. PubMed ID: 23306297
[TBL] [Abstract][Full Text] [Related]
17. Perioperative antithrombotic management in joint replacement surgeries.
Lee HL; Chiu KY; Yiu KH; Ng FY; Yan CH; Chan PK
Hong Kong Med J; 2013 Dec; 19(6):531-8. PubMed ID: 24141860
[TBL] [Abstract][Full Text] [Related]
18. Low-Molecular-Weight Heparin and the Relative Risk of Surgical Site Bleeding Complications: Results of a Systematic Review and Meta-Analysis of Randomized Controlled Trials of Venous Thromboprophylaxis in Patients After Total Joint Arthroplasty.
Suen K; Westh RN; Churilov L; Hardidge AJ
J Arthroplasty; 2017 Sep; 32(9):2911-2919.e6. PubMed ID: 28522244
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness of prolonged thromboprophylaxis after cancer surgery.
Bradley CT; Brasel KJ; Miller JJ; Pappas SG
Ann Surg Oncol; 2010 Jan; 17(1):31-9. PubMed ID: 19707830
[TBL] [Abstract][Full Text] [Related]
20. Aspirin, the Unsung Champion of Deep Venous Thrombosis Chemoprophylaxis: A Historical Perspective: Commentary on an article by Javad Parvizi, MD, FRCS, et al.: "Low-Dose Aspirin Is Effective Chemoprophylaxis Against Clinically Important Venous Thromboembolism Following Total Joint Arthroplasty. A Preliminary Analysis".
Shaw JA
J Bone Joint Surg Am; 2017 Jan; 99(2):e6. PubMed ID: 28099311
[No Abstract] [Full Text] [Related]
[Next] [New Search]
